世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の迅速診断市場 2018-2022年

Global Rapid Diagnostics Market 2018-2022

 

出版社 出版年月電子版価格 ページ数
TechNavio
テクナビオ
2018年2月US$2,500
シングルユーザライセンス
137

サマリー

このレポートは世界の迅速診断市場を調査したTechNavioの調査報告書です。

Report Details

About Rapid Diagnostics
Rapid diagnostic products are used for preliminary and emergency medical screening. These products are developed for medical facilities with low skilled resources.

Technavio’s analysts forecast the global rapid diagnostics market to grow at a CAGR of 7.56% during the period 2018-2022.

Covered in this report
The report covers the present scenario and the growth prospects of the global rapid diagnostics market for 2018-2022. To calculate the market size, the report considers the revenue generated from the rapid diagnostics.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Technavio's report, Global Rapid Diagnostics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott
- BD
- bioMerieux
- Danaher
- F. Hoffmann-La Roche
- Siemens Healthcare



Market driver
- Increasing incidence of chronic and infectious diseases
- For a full, detailed list, view our report

Market challenge
- High cost of rapid diagnostic products
- For a full, detailed list, view our report

Market trend
- Growing presence of OEMs
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?


You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.





目次

Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 05: MARKET SIZING
- Market definition
- Market sizing 2017
- Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY APPLICATION
- Segmentation by application
- Comparison by application
- Blood glucose testing - Market size and forecast 2017-2022
- Cardiometabolic testing - Market size and forecast 2017-2022
- Infectious disease testing - Market size and forecast 2017-2022
- Pregnancy and fertility testing - Market size and forecast 2017-2022
- Fecal occult testing - Market size and forecast 2017-2022
- Toxicology testing - Market size and forecast 2017-2022
- Coagulation testing - Market size and forecast 2017-2022
- Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY END-USER
- Segmentation by end-user
- Hospitals and clinics
- Clinical diagnostic laboratories
- Home care settings
PART 10: REGIONAL LANDSCAPE
- Geographical segmentation
- Regional comparison
- Rapid diagnostics market in Americas
- Rapid diagnostics market in EMEA
- Rapid diagnostics market in APAC
- Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 13: MARKET TRENDS
- Growing presence of OEMs
- Use of digital health in rapid diagnostics for POC
- Increasing number of M&A
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive landscape
PART 15: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Abbott
- BD
- bioMerieux
- Danaher
- F. Hoffmann-La Roche
- Siemens Healthcare
- Other prominent vendors
PART 16: APPENDIX
- List of abbreviations
List of Exhibits
Exhibit 01: Global IVD market
Exhibit 02: Global IVD market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global rapid diagnostics market size 2017
Exhibit 07: Validation techniques employed for market sizing 2017
Exhibit 08: Global rapid diagnostics market size and forecast 2017-2022 ($ mn)
Exhibit 09: Global rapid diagnostics market - Year over year growth 2018-2022 (%)
Exhibit 10: Five forces analysis 2017
Exhibit 11: Five forces analysis 2022
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2017
Exhibit 18: Application - Market share 2017-2022 (%)
Exhibit 19: Comparison by application
Exhibit 20: Blood glucose testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
Exhibit 21: Blood glucose testing by rapid diagnostics - Year over year growth 2018-2022 (%)
Exhibit 22: Cardiometabolic testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
Exhibit 23: Cardiometabolic testing by rapid diagnostics - Year over year growth 2018-2022 (%)
Exhibit 24: Infectious disease testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
Exhibit 25: Infectious disease testing by rapid diagnostics - Year over year growth 2018-2022 (%)
Exhibit 26: Pregnancy and fertility testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
Exhibit 27: Pregnancy and fertility testing by rapid diagnostics - Year over year growth 2018-2022 (%)
Exhibit 28: Fecal occult testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
Exhibit 29: Fecal occult testing by rapid diagnostics - Year over year growth 2018-2022 (%)
Exhibit 30: Toxicology testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
Exhibit 31: Toxicology testing by rapid diagnostics - Year over year growth 2018-2022 (%)
Exhibit 32: Coagulation testing by rapid diagnostics - Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Toxicology testing by rapid diagnostics - Year over year growth 2018-2022 (%)
Exhibit 34: Market opportunity by application
Exhibit 35: Customer landscape
Exhibit 36: Global rapid diagnostics market by end-user - Market share 2017 (%)
Exhibit 37: Global rapid diagnostics market - Market share by geography 2017-2022 (%)
Exhibit 38: Regional comparison
Exhibit 39: Rapid diagnostics market in the Americas - Market size and forecast 2017-2022 ($ mn)
Exhibit 40: Rapid diagnostics market in the Americas - Year over year growth 2018-2022 (%)
Exhibit 41: Top 3 countries in Americas
Exhibit 42: Rapid diagnostics market in EMEA - Market size and forecast 2017-2022 ($ mn)
Exhibit 43: Rapid diagnostics market in EMEA - Year over year growth 2018-2022 (%)
Exhibit 44: Top 3 countries in EMEA
Exhibit 45: Rapid diagnostics market in APAC - Market size and forecast 2017-2022 ($ mn)
Exhibit 46: Rapid diagnostics market in APAC - Year over year growth 2018-2022 (%)
Exhibit 47: Top 3 countries in APAC
Exhibit 48: Market opportunity
Exhibit 49: Market impact analysis of M&A
Exhibit 50: Vendor landscape
Exhibit 51: Landscape disruption
Exhibit 52: Vendors covered
Exhibit 53: Vendor classification
Exhibit 54: Market positioning of vendors
Exhibit 55: Abbott overview
Exhibit 56: Abbott: Business segments
Exhibit 57: Abbott: Organizational developments
Exhibit 58: Abbott: Geographic focus
Exhibit 59: Abbott: Segment focus
Exhibit 60: Abbott: Key offerings
Exhibit 61: Abbott: Key customers
Exhibit 62: BD overview
Exhibit 63: BD - Business segments
Exhibit 64: BD - Organizational developments
Exhibit 65: BD - Geographic focus
Exhibit 66: BD - Segment focus
Exhibit 67: BD - Key offerings
Exhibit 68: BD - Key customers
Exhibit 69: bioMerieux: Overview
Exhibit 70: bioMerieux: Business segments
Exhibit 71: bioMerieux: Organizational developments
Exhibit 72: bioMerieux: Geographic focus
Exhibit 73: bioMerieux: Segment focus
Exhibit 74: bioMerieux: Key offerings
Exhibit 75: bioMerieux: Key customers
Exhibit 76: Danaher: Overview
Exhibit 77: Danaher: Business segments
Exhibit 78: Danaher: Organizational developments
Exhibit 79: Danaher: Geographic focus
Exhibit 80: Danaher: Segment focus
Exhibit 81: Danaher: Key offerings
Exhibit 82: Danaher: Key customers
Exhibit 83: F. Hoffmann-La Roche overview
Exhibit 84: F. Hoffmann-La Roche: Business segments
Exhibit 85: F. Hoffmann-La Roche: Organizational developments
Exhibit 86: F. Hoffmann-La Roche: Geographic focus
Exhibit 87: F. Hoffmann-La Roche: Segment focus
Exhibit 88: F. Hoffmann-La Roche: Key offerings
Exhibit 89: F. Hoffmann-La Roche: Key customers
Exhibit 90: Siemens Healthcare: Overview
Exhibit 91: Siemens Healthcare: Business segments
Exhibit 92: Siemens Healthcare: Organizational developments
Exhibit 93: Siemens Healthcare: Geographic focus
Exhibit 94: Siemens Healthcare: Segment focus
Exhibit 95: Siemens Healthcare: Key offerings
Exhibit 96: Siemens Healthcare: Key customers

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る